Payment overview · 2025
General Payments
$62.33
3 reported records · 2 companies
Healthcare provider profile · identity verified
Marshall C Long, DO
Allopathic & Osteopathic Physicians|Family Medicine · PRINCETON, WV · NPI 1487718672
Verified facts
What the public records show
CMS Open Payments records show Marshall C Long, DO received $62.33 in general payments during 2025 across 3 reported records.
Novo Nordisk Inc accounted for 63.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 118 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 61 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $39.30 | 63.0% | 2 | 2025 |
| Averitas Pharma Inc. | Unresolved — no canonical attribution shown | $23.03 | 37.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $62.33 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $39.30 | 2 | 2025 |
Source payment records
|
|||||
| QUTENZA Normalized: qutenza |
Drug | Averitas Pharma Inc. | $23.03 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $19.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 118 | exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 61 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
118 | 29 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
61 | 20 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 614 | 148 |
| Famotidine | Famotidine | 394 | 113 |
| Omeprazole | Omeprazole | 386 | 115 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 367 | 102 |
| Lisinopril | Lisinopril | 345 | 93 |
| Atorvastatin Calcium | Atorvastatin Calcium | 296 | 81 |
| Amlodipine Besylate | Amlodipine Besylate | 260 | 77 |
| Gabapentin | Gabapentin | 259 | 61 |
| Metoprolol Succinate | Metoprolol Succinate | 256 | 78 |
| Simvastatin | Simvastatin | 256 | 65 |
| Metformin Hcl | Metformin Hcl | 240 | 63 |
| Pantoprazole Sodium | Pantoprazole Sodium | 224 | 65 |
| Hydrochlorothiazide | Hydrochlorothiazide | 218 | 60 |
| Montelukast Sodium | Montelukast Sodium | 212 | 58 |
| Potassium Chloride | Potassium Chloride | 207 | 62 |
| Tramadol Hcl | Tramadol Hcl | 207 | 39 |
| Fluticasone Propionate | Fluticasone Propionate | 201 | 73 |
| Furosemide | Furosemide | 200 | 66 |
| Losartan Potassium | Losartan Potassium | 195 | 62 |
| Jardiance | Empagliflozin | 183 | 52 |
| Eliquis | Apixaban | 182 | 43 |
| Ezetimibe | Ezetimibe | 157 | 49 |
| Irbesartan | Irbesartan | 157 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 148 | 47 |
| Meloxicam | Meloxicam | 146 | 41 |
| Zolpidem Tartrate | Zolpidem Tartrate | 145 | 24 |
| Trazodone Hcl | Trazodone Hcl | 138 | 39 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 120 | 49 |
| Duloxetine Hcl | Duloxetine Hcl | 119 | 27 |
| Ozempic | Semaglutide | 118 | 29 |
| Allopurinol | Allopurinol | 116 | 34 |
| Methylprednisolone | Methylprednisolone | 111 | 72 |
| Pravastatin Sodium | Pravastatin Sodium | 108 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 106 | 33 |
| Doxycycline Hyclate | Doxycycline Hyclate | 104 | 73 |
| Synthroid | Levothyroxine Sodium | 101 | 26 |
| Alendronate Sodium | Alendronate Sodium | 100 | 31 |
| Ibuprofen | Ibuprofen | 100 | 33 |
| Clopidogrel | Clopidogrel Bisulfate | 96 | 30 |
| Glimepiride | Glimepiride | 96 | 26 |
| Escitalopram Oxalate | Escitalopram Oxalate | 89 | 27 |
| Donepezil Hcl | Donepezil Hcl | 85 | 18 |
| Alprazolam | Alprazolam | 79 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 78 | 28 |
| Sertraline Hcl | Sertraline Hcl | 75 | 20 |
| Atenolol | Atenolol | 71 | 20 |
| Fluconazole | Fluconazole | 70 | 33 |
| Lorazepam | Lorazepam | 68 | 16 |
| Celecoxib | Celecoxib | 67 | 17 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 67 | 22 |
| Diclofenac Sodium | Diclofenac Sodium | 67 | 14 |
| Amitriptyline Hcl | Amitriptyline Hcl | 65 | 18 |
| Prednisone | Prednisone | 61 | 22 |
| Rybelsus | Semaglutide | 61 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 60 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 59 | 14 |
| Sucralfate | Sucralfate | 59 | 15 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 59 | 18 |
| Finasteride | Finasteride | 57 | 18 |
| Clonazepam | Clonazepam | 56 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 55 | 15 |
| Pregabalin | Pregabalin | 55 | 14 |
| Baclofen | Baclofen | 54 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 53 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 53 | 12 |
| Linzess | Linaclotide | 52 | 14 |
| Symbicort | Budesonide/Formoterol Fumarate | 52 | 17 |
| Metformin Hcl Er | Metformin Hcl | 48 | 14 |
| Mupirocin | Mupirocin | 48 | 28 |
| Naproxen | Naproxen | 48 | 16 |
| Buspirone Hcl | Buspirone Hcl | 47 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 47 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 47 | 23 |
| Amoxicillin | Amoxicillin | 45 | 30 |
| Fluoxetine Hcl | Fluoxetine Hcl | 45 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 44 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 44 | 12 |
| Lansoprazole | Lansoprazole | 44 | 11 |
| Mounjaro | Tirzepatide | 44 | suppressed |
| Spironolactone | Spironolactone | 43 | 14 |
| Mirtazapine | Mirtazapine | 41 | 19 |
| Trulicity | Dulaglutide | 41 | suppressed |
| Carvedilol | Carvedilol | 39 | 14 |
| Lidocaine | Lidocaine | 39 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 39 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 37 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 36 | 17 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 35 | 12 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | 11 |
| Meclizine Hcl | Meclizine Hcl | 35 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 34 | suppressed |
| Bupropion Xl | Bupropion Hcl | 31 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 31 | 21 |
| Memantine Hcl | Memantine Hcl | 31 | suppressed |
| Nystatin | Nystatin | 30 | 19 |
| Valsartan | Valsartan | 30 | suppressed |
| Azithromycin | Azithromycin | 29 | 20 |
| Januvia | Sitagliptin Phosphate | 29 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 28 | suppressed |
| Glipizide | Glipizide | 28 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 28 | suppressed |
| Phenobarbital | Phenobarbital | 28 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 28 | 13 |
| Bethanechol Chloride | Bethanechol Chloride | 27 | suppressed |
| Cefdinir | Cefdinir | 27 | 22 |
| Ketoconazole | Ketoconazole | 27 | 16 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 27 | suppressed |
| Nitroglycerin | Nitroglycerin | 27 | 17 |
| Testosterone Cypionate | Testosterone Cypionate | 27 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 27 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 26 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 25 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 16 |
| Cephalexin | Cephalexin | 24 | 18 |
| Temazepam | Temazepam | 24 | suppressed |
| Hydrocortisone | Hydrocortisone | 23 | suppressed |
| Methocarbamol | Methocarbamol | 23 | suppressed |
| Diazepam | Diazepam | 22 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 22 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 22 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 22 | 21 |
| Raloxifene Hcl | Raloxifene Hcl | 22 | suppressed |
| Sotalol | Sotalol Hcl | 22 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 22 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 22 | suppressed |
| Tradjenta | Linagliptin | 22 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 22 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 21 | 17 |
| Colestipol Hcl | Colestipol Hcl | 21 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 21 | suppressed |
| Gemfibrozil | Gemfibrozil | 21 | suppressed |
| Levetiracetam | Levetiracetam | 21 | suppressed |
| Levofloxacin | Levofloxacin | 21 | 18 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 20 | suppressed |
| Klor-Con M20 | Potassium Chloride | 20 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Ramipril | Ramipril | 20 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 19 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 19 | suppressed |
| Latanoprost | Latanoprost | 19 | suppressed |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Repatha Sureclick | Evolocumab | 19 | suppressed |
| Azelastine-Fluticasone | Azelastine/Fluticasone | 18 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 18 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 18 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 18 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Digoxin | Digoxin | 17 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 17 | suppressed |
| Perindopril Erbumine | Perindopril Erbumine | 17 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 16 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 16 | suppressed |
| Methotrexate | Methotrexate Sodium | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Promethazine Hcl | Promethazine Hcl | 16 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Niacin Er | Niacin | 15 | suppressed |
| Topiramate | Topiramate | 15 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Galantamine Er | Galantamine Hbr | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 13 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Fenofibric Acid | Fenofibric Acid (Choline) | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 12 | suppressed |
| Xarelto | Rivaroxaban | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 11 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Ibu | Ibuprofen | 11 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 11 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $62.33 · 3 records | Novo Nordisk Inc | Ozempic, QUTENZA, Rybelsus | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error